TY - JOUR
T1 - Integrated Multiregional Analysis Proposing a New Model of Colorectal Cancer Evolution
AU - Uchi, Ryutaro
AU - Takahashi, Yusuke
AU - Niida, Atsushi
AU - Shimamura, Teppei
AU - Hirata, Hidenari
AU - Sugimachi, Keishi
AU - Sawada, Genta
AU - Iwaya, Takeshi
AU - Kurashige, Junji
AU - Shinden, Yoshiaki
AU - Iguchi, Tomohiro
AU - Eguchi, Hidetoshi
AU - Chiba, Kenichi
AU - Shiraishi, Yuichi
AU - Nagae, Genta
AU - Yoshida, Kenichi
AU - Nagata, Yasunobu
AU - Haeno, Hiroshi
AU - Yamamoto, Hirofumi
AU - Ishii, Hideshi
AU - Doki, Yuichiro
AU - Iinuma, Hisae
AU - Sasaki, Shin
AU - Nagayama, Satoshi
AU - Yamada, Kazutaka
AU - Yachida, Shinichi
AU - Kato, Mamoru
AU - Shibata, Tatsuhiro
AU - Oki, Eiji
AU - Saeki, Hiroshi
AU - Shirabe, Ken
AU - Oda, Yoshinao
AU - Maehara, Yoshihiko
AU - Komune, Shizuo
AU - Mori, Masaki
AU - Suzuki, Yutaka
AU - Yamamoto, Ken
AU - Aburatani, Hiroyuki
AU - Ogawa, Seishi
AU - Miyano, Satoru
AU - Mimori, Koshi
N1 - Funding Information:
The present study was supported in part by the following grants and foundation; CREST, Japan Science and Technology Agency (JST), the Funding Program for Next Generation World-Leading Researchers (LS094), Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Scientific Research, grant number 25861199, Grantsin- Aid for Scientific Research on Innovative Areas of Ministry of Education, Culture, Sports, Science, and Technology ?Systems Cancer Research? (4201), and The MEXT Strategic Programs on Innovative Research ?Supercomputational Life Science?, and the YASUDA Medical Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
PY - 2016/2
Y1 - 2016/2
N2 - Understanding intratumor heterogeneity is clinically important because it could cause therapeutic failure by fostering evolutionary adaptation. To this end, we profiled the genome and epigenome in multiple regions within each of nine colorectal tumors. Extensive intertumor heterogeneity is observed, from which we inferred the evolutionary history of the tumors. First, clonally shared alterations appeared, in which C>T transitions at CpG site and CpG island hypermethylation were relatively enriched. Correlation between mutation counts and patients’ ages suggests that the early-acquired alterations resulted from aging. In the late phase, a parental clone was branched into numerous subclones. Known driver alterations were observed frequently in the early-acquired alterations, but rarely in the late-acquired alterations. Consistently, our computational simulation of the branching evolution suggests that extensive intratumor heterogeneity could be generated by neutral evolution. Collectively, we propose a new model of colorectal cancer evolution, which is useful for understanding and confronting this heterogeneous disease.
AB - Understanding intratumor heterogeneity is clinically important because it could cause therapeutic failure by fostering evolutionary adaptation. To this end, we profiled the genome and epigenome in multiple regions within each of nine colorectal tumors. Extensive intertumor heterogeneity is observed, from which we inferred the evolutionary history of the tumors. First, clonally shared alterations appeared, in which C>T transitions at CpG site and CpG island hypermethylation were relatively enriched. Correlation between mutation counts and patients’ ages suggests that the early-acquired alterations resulted from aging. In the late phase, a parental clone was branched into numerous subclones. Known driver alterations were observed frequently in the early-acquired alterations, but rarely in the late-acquired alterations. Consistently, our computational simulation of the branching evolution suggests that extensive intratumor heterogeneity could be generated by neutral evolution. Collectively, we propose a new model of colorectal cancer evolution, which is useful for understanding and confronting this heterogeneous disease.
UR - http://www.scopus.com/inward/record.url?scp=84959902916&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84959902916&partnerID=8YFLogxK
U2 - 10.1371/journal.pgen.1005778
DO - 10.1371/journal.pgen.1005778
M3 - Article
C2 - 26890883
AN - SCOPUS:84959902916
VL - 12
JO - PLoS Genetics
JF - PLoS Genetics
SN - 1553-7390
IS - 2
M1 - e1005778
ER -